Researchers are reporting a new molecular marker that can help doctors assess the risk of heart attack, stroke and other cardiovascular diseases.It is a protein called serum amyloid alpha (SAA), which is associated with the inflammation that has emerged recently as a leading factor in cardiovascular disease.
